DK23981A - Agmatinderivater og salte deraf deres fremstilling og anvendelse - Google Patents

Agmatinderivater og salte deraf deres fremstilling og anvendelse

Info

Publication number
DK23981A
DK23981A DK23981A DK23981A DK23981A DK 23981 A DK23981 A DK 23981A DK 23981 A DK23981 A DK 23981A DK 23981 A DK23981 A DK 23981A DK 23981 A DK23981 A DK 23981A
Authority
DK
Denmark
Prior art keywords
agmatin
derivatives
salts
preparation
application
Prior art date
Application number
DK23981A
Other languages
English (en)
Other versions
DK150204C (da
DK150204B (da
Inventor
S Bajusz
E Szell
E Barabas
D Bagdy
Z Mohai
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK23981A publication Critical patent/DK23981A/da
Publication of DK150204B publication Critical patent/DK150204B/da
Application granted granted Critical
Publication of DK150204C publication Critical patent/DK150204C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK023981A 1979-06-12 1981-01-20 Analogifremgangsmaade til fremstilling af dipeptidyl-agmatiner eller deres hydrochlorider DK150204C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU79GO1449A HU178398B (en) 1979-06-12 1979-06-12 Process for producing new agmatine derivatives of activity against haemagglutination
HU144980 1980-10-07

Publications (3)

Publication Number Publication Date
DK23981A true DK23981A (da) 1982-04-08
DK150204B DK150204B (da) 1987-01-05
DK150204C DK150204C (da) 1987-10-19

Family

ID=10996896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK023981A DK150204C (da) 1979-06-12 1981-01-20 Analogifremgangsmaade til fremstilling af dipeptidyl-agmatiner eller deres hydrochlorider

Country Status (17)

Country Link
US (1) US4346078A (da)
JP (1) JPS5764653A (da)
AT (1) AT384228B (da)
AU (1) AU535688B2 (da)
BE (1) BE887224A (da)
CA (1) CA1158641A (da)
CH (1) CH649561A5 (da)
DE (1) DE3108810A1 (da)
DK (1) DK150204C (da)
FR (1) FR2491463B1 (da)
GB (1) GB2085444B (da)
HU (1) HU178398B (da)
IL (1) IL62018A (da)
IT (1) IT1168107B (da)
NL (1) NL8100391A (da)
SE (1) SE452326B (da)
SU (1) SU1178322A3 (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968808C (de) * 1949-11-01 1958-04-03 Hermann Schilling Dipl Ing Baeuerliches Motorvielfachgeraet mit einachsigem Motorgrundgeraet
US4088040A (en) * 1977-01-03 1978-05-09 Ross Myring Brian 360° Cable actuating lever

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219846B (it) * 1988-02-24 1990-05-24 Consiglio Nazionale Ricerche Nuovi derivati guandinici ad attivita' ipotensia,composizione che li contengono e relativo procedimento di estrazione e purificazione da materiale botanico
FR2656608B1 (fr) * 1989-12-28 1992-04-24 Roussel Uclaf Nouvelles polyamines benzoylees, leur procede de preparation et leur application comme fongicides.
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
US5416093A (en) * 1991-11-12 1995-05-16 Eli Lilly And Company Antithrombotic agents
US5252566A (en) * 1991-11-12 1993-10-12 Eli Lilly And Company Antithrombotic agents
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE507295C2 (sv) * 1992-01-18 1998-05-11 Thyssen Nordseewerke Gmbh Värmeisoleringsformkroppar
US6534536B1 (en) 1994-03-16 2003-03-18 Bristol-Myers Squibb Company Alkylsulfonamido heterocyclic thrombin inhibitors
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
ES2184763T3 (es) * 1993-04-30 2003-04-16 Merck & Co Inc Inhibidores de trombina.
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301911D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptide derivatives
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
SE9301912D0 (sv) 1993-06-03 1993-06-03 Ab Astra Process for the production of aminoalkylguandines
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5498724A (en) * 1994-06-28 1996-03-12 Aktiebolaget Astra Pyrazoleamidine compounds
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
WO1996025426A1 (de) * 1995-02-17 1996-08-22 Basf Aktiengesellschaft Neue dipeptidische amidine als thrombin-inhibitoren
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
US5811402A (en) * 1996-03-22 1998-09-22 Eli Lilly And Company Antithrombotic diamides
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
WO1997049404A1 (en) * 1996-06-25 1997-12-31 Eli Lilly And Company Anticoagulant agents
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
CN1289341A (zh) 1998-01-26 2001-03-28 Basf公司 凝血酶抑制剂
US6417161B1 (en) 1998-04-24 2002-07-09 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
SE9804313D0 (sv) * 1998-12-14 1998-12-14 Astra Ab New compounds
CA2355792A1 (en) 1999-01-13 2000-07-20 Astrazeneca Ab New amidinobenzylamine derivatives and their use as thrombin inhibitors
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
CA2431588A1 (en) 2000-12-18 2002-06-27 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US7144899B2 (en) 2001-02-09 2006-12-05 Merck & Co., Inc. Thrombin inhibitors
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
CA2453202C (en) * 2001-07-06 2012-10-16 Oregon Health & Science University Peptides which modulate blood coagulation and methods of use thereof
US7084134B2 (en) * 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors
SE0201374D0 (sv) * 2002-05-06 2002-05-06 Astrazeneca Ab Pharmaceutical combination
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
CN102464701B (zh) 2010-11-08 2015-10-21 上海医药工业研究院 一类新型化合物、其制备方法及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968808C (de) * 1949-11-01 1958-04-03 Hermann Schilling Dipl Ing Baeuerliches Motorvielfachgeraet mit einachsigem Motorgrundgeraet
US4088040A (en) * 1977-01-03 1978-05-09 Ross Myring Brian 360° Cable actuating lever

Also Published As

Publication number Publication date
US4346078A (en) 1982-08-24
AT384228B (de) 1987-10-12
NL8100391A (nl) 1982-05-03
DE3108810A1 (de) 1982-05-19
DK150204C (da) 1987-10-19
ATA43681A (de) 1987-03-15
AU535688B2 (en) 1984-03-29
CH649561A5 (en) 1985-05-31
SE8100302L (sv) 1982-04-08
HU178398B (en) 1982-04-28
CA1158641A (en) 1983-12-13
GB2085444B (en) 1984-02-15
DK150204B (da) 1987-01-05
IL62018A0 (en) 1981-02-27
AU6672581A (en) 1982-04-22
FR2491463B1 (da) 1984-08-17
JPS5764653A (en) 1982-04-19
SE452326B (sv) 1987-11-23
IL62018A (en) 1984-03-30
SU1178322A3 (ru) 1985-09-07
IT1168107B (it) 1987-05-20
GB2085444A (en) 1982-04-28
BE887224A (fr) 1981-07-27
FR2491463A1 (da) 1982-04-09
IT8120107A0 (it) 1981-03-04

Similar Documents

Publication Publication Date Title
DK23981A (da) Agmatinderivater og salte deraf deres fremstilling og anvendelse
DK93880A (da) Polyolderivater samt deres fremstilling og anvendelse
DK377678A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
DK319480A (da) Muramylpeptidforbindelser samt deres fremstilling og anvendelse
DK143378A (da) Cephemderivater deres fremstilling og anvndelse
DK531479A (da) Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
DK61887D0 (da) Substituerede 5-amino-4-hydroxy-valerylderivater og salte deraf samt deres fremstilling og anvendelse
DK395580A (da) Aminosyrederivater deres fremstilling og anvendelse
NO800501L (no) Antibakterielle midler og beta-laktamasehemmere og fremgangsmaate for deres fremstilling
DK404180A (da) Polyetherpolyaminer og salte deraf deres fremstilling og anvendelse
DK477578A (da) Imidazolinderivater og salte deraf samt deres fremstilling og anvendelse
DK539979A (da) Quinazolinonderivater samt deres fremstilling og anvndelse
DK212778A (da) Sesquiterpen-derivater og salte deraf samt fremgangsmaade til deres fremstilling
DK476978A (da) Tetrazolderivater eller farmaceutisk uskadelige salte deraf deres fremstilling og anvendelse
DK483481A (da) Enkephalinderivater og farmaceutisk acceptable salte deraf deres fremstilling og anvendelse
DK38587D0 (da) Mono- og disaccharidylderivater og salte deraf samt deres fremstilling og anvendelse
DK451080A (da) Homoserinderivater samt deres fremstilling og anvendelse som mikrobicider
DK286480A (da) Oxinethere deres fremstilling og anvendelse
DK469879A (da) Adenosintriphosphatderivat og salte deraf
DK429780A (da) 1,2,4-oxadiazolin-5-on-derivater eller syreadditionssalte eller kvaternaere salte deraf og deres fremstilling
DK556483D0 (da) Benzofuranylderivater og deres fremstilling
DK61386A (da) N-substituerede butyramidderivater og salte deraf samt deres fremstilling og anvendelse
DK291380A (da) Amino-thiadiazolylforbindelser samt deres fremstilling og anvendelse
DK131379A (da) Steroid-spiro-oxazolderivater deres fremstilling og anvendelse
DK222384A (da) 2-aminolavalkyl-2-penem-forbindelser og salte deraf samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PBP Patent lapsed